{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Ta de Clinicagem","title":"TdC em Bolus - Metformina, o que você precisa saber","html":"","width":"100%","height":180,"duration":723,"description":"Chegou o TdC em Bolus! Podcast curto que vai chegar a cada duas semanas pra vocês, trabalhando temas rápidos e com o tamanho perfeito pra ouvir sem nem perceber e indicar para quem ainda não está no mundo dos podcasts. \nNesse primeiro episódio, Pedro vem falar da Metformina! Como começar, vantagens e desvantagens, tudo aqui!\nReferências\n1. FLORY, James; LIPSKA, Kasia. Metformin in 2019. Jama, v. 321, n. 19, p. 1926-1927, 2019.\n2. INZUCCHI, Silvio E. et al. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. Jama, v. 312, n. 24, p. 2668-2675, 2014.\n3. CROWLEY, Matthew J. et al. Clinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic review. Annals of internal medicine, v. 166, n. 3, p. 191-200, 2017.\n4. OUT, Mattijs et al. Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: post hoc analysis of a randomized controlled 4.3 year trial. Journal of Diabetes and its Complications, v. 32, n. 2, p. 171-178, 2018.\n5. Kaplan DE et al. Effects of metformin exposure on survival in a large national cohort of patients with diabetes and cirrhosis. Clin Gastroenterol Hepatol 2020 Aug 12; [e-pub].\n6. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetesd2021. Diabetes Care 2021;44(Suppl. 1):S111–S124","thumbnail_url":"https://img.transistorcdn.com/lqcQlEC1m6aWV5CJqKTqNKKWbLXziZKK97FisF4ZuuE/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lODM1/ZmI0ODIxZjAxM2U1/ZGUwMjhkYTYwNzZi/MGNmNi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}